Certain Inflammatory Bowel Disease
Best of IBD Summit: Optimizing Selections From the Therapeutic Menu
This activity is supported by educational grants from AbbVie Inc.; Bristol Myers Squibb; Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; and Takeda Pharmaceuticals U.S.A., Inc.
IBD specialists, nonphysician practitioners have greater EHR burden in gastroenterology
CHARLOTTE, N.C. — In gastroenterology practices, inflammatory bowel disease specialists and nonphysician practitioners experienced increased electronic health record burden, according to a presenter at the ACG Annual Scientific Meeting.
Skyrizi induction, maintenance therapy improves patient-reported symptoms in CD
CHARLOTTE, N.C. — Patient-reported outcomes of abdominal pain and stool frequency improved with risankizumab induction, while maintenance therapy was effective for symptomatic remission and resolution in patients with Crohn’s disease.
VIDEO: Telemedicine changes face of care for IBD patients
In this video exclusive, Tina Aswani Omprakash, a patient advocate with Crohn's disease, discussed how telemedicine changed patient care.